Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1992 2
1996 1
1997 3
1998 2
1999 2
2000 1
2001 1
2002 2
2003 5
2004 2
2005 3
2006 5
2007 2
2008 3
2009 2
2010 7
2011 5
2012 6
2013 6
2014 11
2015 6
2016 8
2017 4
2018 9
2019 12
2020 9
2021 5
2022 4
2023 11
2024 19
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
State-of-the-art 2023 on gene therapy for phenylketonuria.
Martinez M, Harding CO, Schwank G, Thöny B. Martinez M, et al. Among authors: harding co. J Inherit Metab Dis. 2024 Jan;47(1):80-92. doi: 10.1002/jimd.12651. Epub 2023 Aug 3. J Inherit Metab Dis. 2024. PMID: 37401651 Free PMC article. Review.
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
Thomas J, Levy H, Amato S, Vockley J, Zori R, Dimmock D, Harding CO, Bilder DA, Weng HH, Olbertz J, Merilainen M, Jiang J, Larimore K, Gupta S, Gu Z, Northrup H; PRISM investigators. Thomas J, et al. Among authors: harding co. Mol Genet Metab. 2018 May;124(1):27-38. doi: 10.1016/j.ymgme.2018.03.006. Epub 2018 Mar 31. Mol Genet Metab. 2018. PMID: 29653686 Free article. Clinical Trial.
Letter to the editor.
Harding CO, Martinez M. Harding CO, et al. HGG Adv. 2024 Jul 18;5(3):100308. doi: 10.1016/j.xhgg.2024.100308. Epub 2024 May 14. HGG Adv. 2024. PMID: 38848211 Free PMC article. No abstract available.
Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders.
Posset R, Garbade SF, Gleich F, Scharre S, Okun JG, Gropman AL, Nagamani SCS, Druck AC, Epp F, Hoffmann GF, Kölker S, Zielonka M; Urea Cycle Disorders Consortium (UCDC); European registry and network for Intoxication type Metabolic Diseases (E-IMD) Consortia Study Group. Posset R, et al. Genet Med. 2024 Apr;26(4):101039. doi: 10.1016/j.gim.2023.101039. Epub 2023 Dec 3. Genet Med. 2024. PMID: 38054409 Free article.
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria.
Grisch-Chan HM, Schwank G, Harding CO, Thöny B. Grisch-Chan HM, et al. Among authors: harding co. Hum Gene Ther. 2019 Oct;30(10):1274-1283. doi: 10.1089/hum.2019.111. Epub 2019 Sep 9. Hum Gene Ther. 2019. PMID: 31364419 Free PMC article. Review.
Meta-analysis of bone mineral density in adults with phenylketonuria.
Rocha JC, Hermida Á, Jones CJ, Wu Y, Clague GE, Rose S, Whitehall KB, Ahring KK, Pessoa ALS, Harding CO, Rohr F, Inwood A, Longo N, Muntau AC, Sivri S, Maillot F. Rocha JC, et al. Among authors: harding co. Orphanet J Rare Dis. 2024 Sep 12;19(1):338. doi: 10.1186/s13023-024-03223-9. Orphanet J Rare Dis. 2024. PMID: 39267130 Free PMC article.
Phenylketonuria in adults: we know plenty, but there is much more to learn.
Harding CO, Arnold G, Berry GT, Christ SE, Grange DK, Jurecki E, Levy H, Lichter-Konecki U, Longo N, McNutt M, Meachum P, Sacharow S, Shayota B, Thomas J, Vucko E; Members of the PHEFREE Consortium. Harding CO, et al. Am J Clin Nutr. 2025 Mar;121(3):741-743. doi: 10.1016/j.ajcnut.2024.12.024. Epub 2025 Jan 24. Am J Clin Nutr. 2025. PMID: 40044395 Free PMC article. No abstract available.
148 results